Hyperphosphaturia

Known as: Phosphaturia 
An increased excretion of phosphates in the urine. [HPO:curators]
National Institutes of Health

Related topics

Related topics

6 relations
Cytochrome-c Oxidase DeficiencyDent disease 1Hepatolenticular DegenerationHyperphosphatemia (disorder)
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.
BACKGROUND AND OBJECTIVES Patients with advanced chronic kidney disease (CKD) are in positive phosphorus balance, but phosphorus… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule.
Klotho has profound effects on phosphate metabolism, but the mechanisms of how Klotho affects phosphate homeostasis is unknown… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) target the kidney to cause a phosphaturia. FGF23 also acts on… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study.
CONTEXT Parenteral iron administration has been associated with hypophosphatemia. Fibroblast growth factor 23 (FGF23) has a… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.
Normophosphatemia and normocalcemia are maintained in chronic kidney disease (CKD) by increased levels of fibroblast growth… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
Hyperphosphatemia, calcitriol deficiency, and secondary hyperparathyroidism (SHPT) are common complications of chronic kidney… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2004
2004
Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets.
MEPE (Matrix Extracellular PhosphoglycoprotEin) expression is markedly elevated in X-linked-hypophosphatemic-rickets (HYP) and… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism.
Oncogenic osteomalacia (OOM) is associated with primitive mesenchymal tumors that secrete phosphaturic factors resulting in low… (More)
Is this relevant?
Review
1997
Review
1997
Renal effects of environmental and occupational lead exposure.
Environmental and industrial lead exposures continue to pose major public health problems in children and in adults. Acute… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?
Review
1992
Review
1992
Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease.
Control of phosphorus accumulation in chronic renal insufficiency is crucial to the prevention of secondary hyperparathyroidism… (More)
Is this relevant?